Nuclear translocation of EGFR has recently been appreciated to strongly correlate with oncogenic outcomes in various cancers, involving both kinase-dependent and –independent functions of nEGFR, and further characterization of the molecular events involved in spatial regulation of EGFR are critically important in the development of novel therapeutics34. This evidence concerns the gene EGFR and cancer.